Erdosteine Unknown Status Phase 3 Trials for Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01032304The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)